Navigation Links
CytoVas And BD Biosciences Ink Alliance To Co-Develop Personalized Diagnostic For Vascular Health
Date:4/25/2013

tor Program, an initiative designed to speed the investigation and development of products to help people with cardiovascular disease.

"In the current landscape, it's not easy for research discoveries to forge a rapid path toward patient benefit," said Dr. Moore, a world-renowned expert in flow cytometry, Professor of Pathology and Laboratory Medicine, and Director of Clinical and Research Flow Cytometry at the Perelman School of Medicine. "The partnership with BD is a promising step in bridging the gap from research to patients for this potentially life-saving diagnostic."  

The partnership enables CytoVas to investigate the Vascular Health Profile's capacity to assess cardiovascular disease progression, as well as the cardiovascular-related efficacy and side effect profiles of existing and experimental medicines.  The Company already has studies underway with several therapies to that end.

"I believe the VHP will become instrumental in guiding treatment decisions by helping us understand what is happening – in real time – at the actual site of a patient's atherosclerotic plaque, the endothelium," said Noel Warner , PhD, Worldwide Vice President, Scientific Affairs, BD Biosciences.  "This could be instrumental in guiding clinical treatment as well as aiding industry as a biomarker or companion diagnostic for therapeutic innovation." 

"For the American healthcare system, the Vascular Health Profile is a potential game-changer," said Ross Tonkens , a cardiologist and head of the American Heart Association's Science & Technology Accelerator Fund.  "This test not only offers the promise of identifying symptom-free individuals at high risk, but could also assess the effectiveness of new therapies to prevent heart attack and stroke."

Cytovas and BD expect their current strategic alliance to run for at least two years, at the end of which
'/>"/>

SOURCE CytoVas
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference
2. Chipscreen Biosciences Announces Achievement of Primary Endpoint in Chidamide Registrational Trial in China
3. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
4. Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
5. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
6. Industry Veteran Katrine Bosley Joins Genocea Biosciences Board Of Directors
7. Pressure BioSciences, Inc. to Present at the SeeThruEquity Spring Investor Microcap Forum
8. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
9. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
10. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
11. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... , Aug. 1, 2014 MGC Diagnostics ... company, announced today that it has completed its ... of cardiorespiratory diagnostic products based in Sorinnes, ... served the European cardiorespiratory diagnostics market since 1977. ... of approximately €4.7 million ($6.3 million) and incurred ...
(Date:8/1/2014)... 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... are used to develop, manufacture and sell enzymes and ... industrial enzyme industries, announced today that it will report ... 30, 2014 after market close on Thursday, August 14, ... at 5:00 p.m. Eastern Time to discuss those results. ...
(Date:7/31/2014)... SAN DIEGO , July 31, 2014  Sorrento Therapeutics, ... death of Mr. Amar Singh , Chief Business Officer ... of apparent natural causes on July 30. "Sorrento ... dear friend and colleague. Our immediate thoughts go to Amar,s ... President and Chief Executive Officer. Mr. Singh ...
Breaking Medicine Technology:MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 3MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 4Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3Sorrento Announces the Unexpected Death of its Chief Business Officer 2
... 2, 2012  Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased ... the month of February, its Food and Drug Administration ... NAI (No Action Indicated) for the inspection. ... perform unannounced inspections for medical device manufacturers and the ...
... N.J., March 2, 2012 Watson Pharmaceuticals, Inc. ... Watson has launched an authorized generic version of ... part of an agreement with Abbott Laboratories. Watson ... indicated for use in the prevention of endometrial ...
Cached Medicine Technology:Solos Endoscopy, Inc. Successfully Completes Level I FDA Inspection 2Watson Launches Generic PROMETRIUM(R) 2
(Date:8/1/2014)... 01, 2014 On Monday, June 30th, ... User Symposium in San Francisco, CA. Now in its ... JW Marriott Union Square hotel. , “We are excited ... to speed with ACA compliance issues,” Quirk Healthcare Foundation ... symposium provides attendees guidance with NextGen implementation and use, ...
(Date:8/1/2014)... Alan Mozes HealthDay Reporter ... country, barbershops serve as a time-honored destination for a good ... whether barbershops might also be the spot to tackle an ... In a novel partnership, the U.S. Centers for Disease ... Health (MSDH), enlisted the help of barbershop staff to both ...
(Date:8/1/2014)... The North America Endpoint Security Market report defines and ... with analysis and forecast of revenue. This market is ... to $4.77 billion by 2019, at a CAGR of ... TOC of the North America Endpoint Security Market report ... It also provides a glimpse of the segmentation in ...
(Date:8/1/2014)... 1, 2014 The Cardiovascular Research Foundation (CRF) ... investigations that will be presented at next month,s ... the world,s premier educational meeting specializing in interventional ... 17, 2014 at the Walter E. Washington Convention ... presented at TCT often direct the course of ...
(Date:8/1/2014)... NY (PRWEB) August 01, 2014 ... The company develops biomarkers. Its products include CytoSure ... ISCA +SNP Array, CytoSure ISCA UPD array, CytoSure ... v2 array. OGT offers services, such as targeted ... RNA-Seq service, miRNA analysis, gene expression analysis, cytosure ...
Breaking Medicine News(10 mins):Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 3
... SALAAM, Tanzania, April 25 Today is a,great day for ... and a day to,celebrate. We celebrate because of the possibilities ... today by the United,Nations Secretary General His Excellency Ban Ki-Moon, ... initiative is implemented to the,letter, millions of lives will be ...
... Inc. (NYSE:,NTY) (http://www.NBTY.com ), a leading global manufacturer ... web cast the,presentation by Harvey Kamil, President and Chief ... And Restaurant Conference in,New York on Tuesday, April 29, ... cast live on the Company Web,site, http://www.nbty.com ...
... (Nasdaq: THOR ), a world leader in ... restore failing hearts,today announced that it will report ... 2008 on Thursday, May 1., The company ... financial,results and operating activities to all interested parties ...
... and who,s telling the truth , , FRIDAY, April 25 ... window into the soul, but scientists have been reporting ... imperceptible facial expressions -- tell the real story of ... that people have a lot more trouble hiding their ...
... and reduced risk of recurrence during tuberculosis chemotherapy, according ... of The Journal of Infectious Diseases, now available online. ... common before the advent of anti-TB drugs, is no ... low-income countries even though poor nutrition impairs the immune ...
... Inc.,(Nasdaq: SMBL ) will hold its annual meeting ... 2008, at the Teaneck Marriott at Glenpointe, 100,Frank W. ... the close of business on April 2, 2008, are ... come before the meeting., About Smart Balance Inc., ...
Cached Medicine News:Health News:Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria 2Health News:NBTY to Webcast Presentation at Lehman Brothers 11th Annual Retail and Restaurant Conference 2Health News:Thoratec Schedules First Quarter 2008 Conference Call, Webcast 2Health News:Fleeting Facial Expressions Reveal Deep Secrets 2Health News:Fleeting Facial Expressions Reveal Deep Secrets 3Health News:Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence 2
... For Excellent Drainage PLUS Greater Patient ... BLAKE Drains are white, radiopaque silicone drains ... a solid core center. Their other components ... extension tubing and an adapter. The drains ...
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte...
Used for internal biliary drainage. Supplied sterile in peel-open packages. Intended for one-time use....
Used for common bile duct exploration. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: